Bausch + Lomb/$BLCO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Bausch + Lomb

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Ticker

$BLCO
Sector

Primary listing

NYSE

Employees

13,500

Headquarters

Vaughan, Canada

Bausch + Lomb Metrics

BasicAdvanced
$5.2B
-
-$0.78
0.63
-

Bulls say / Bears say

The IPO in May 2025 priced 35 million shares at $18, below its $21–$24 target range, reflecting weaker-than-anticipated investor demand and raising concerns about the company’s growth outlook (Reuters).
Board members Brett Icahn and Gary Hu resigned on August 18, 2025, after Carl Icahn’s agreement ended, potentially creating a period of governance uncertainty and strategic distraction (Reuters).
Alcon’s FDA approval of its new dry-eye treatment Tryptyr on May 28, 2025, intensifies competition in the dry-eye market and may pressure sales of Bausch + Lomb’s Xiidra franchise (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 7 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BLCO

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs